Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial

Pieter C. Smits(Cardiovascular European Research Center), Alfredo E. Rodríguez(Sanatorio Otamendi y Miroli), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Felix Mahfoud(University of Basel), Antonio Colombo(Humanitas University), Marco Valgimigli(University of Bern), Andrés Íñiguez(University Hospital Complex Of Vigo), Mirvat Alasnag(King Fahd Armed Forces Hospital), Peter Jüni(University of Oxford), Jozef Bartúnek(University of Oxford), Peep Laanmets(North Estonia Medical Centre), Ran Kornowski(Tel Aviv University), Yukio Ozaki(Kyushu University), Goran Stanković(University of Belgrade), Dik Heg, Stephan Windecker(University of Bern), Pascal Vranckx(Jessa Hospital), Marco Roffi(University of Geneva), Carl Schultz(The University of Western Australia), Bernard Chevalier(University of Zurich), David Hildick‐Smith(Sussex County Community College), Maciej Lesiak, Paul Jau Lueng Ong(Tan Tock Seng Hospital), Marie‐Claude Morice(Cardiovascular European Research Center), Jan G.P. Tijssen(Amsterdam UMC Location University of Amsterdam), Enrico Frigoli(University of Bern), Pim A.L. Tonino(Radboud University Nijmegen), Aris Moschovitis(University of Bern)
Circulation
August 29, 2021
Cited by 77


Related Papers